The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Peanut Allergy Treatment Global Market Report 2024, the peanut allergy treatment market is expected to show significant growth in the forecast period.

Market Size and Growth Projections

• 2023 to 2024: The peanut allergy treatment market is set to grow from $0.41 billion in 2023 to $0.45 billion in 2024, reflecting a compound annual growth rate (CAGR) of 11.1%.
• 2024 to 2028: This market is expected to expand further, reaching $0.69 billion by 2028 with a CAGR of 11.2%.

Drivers of Historical Growth

• Increased Prevalence: Rising cases of peanut allergies worldwide.
• Advancements in Diagnostic Testing: Improved methods for early detection.
• Public Awareness: Greater recognition and concern over peanut allergies.
• Early Intervention Strategies: Development of new treatment protocols.
• Regulatory Approvals: More treatments gaining official approval.

Future Growth Catalysts
Expected Growth Drivers

• Prevalence Rise: Continued increase in peanut allergy cases.
• Personalized Medicine: Expansion in tailored treatment approaches.
• Novel Immunotherapy Treatments: Introduction of new, effective therapies.
• Investment Growth: Increased funding from public and private sectors.
• Telemedicine Services: Expansion of remote healthcare services.

View More On The Peanut Allergy Treatment Market Report 2024 – https://www.thebusinessresearchcompany.com/report/peanut-allergy-treatment-global-market-report

 Key Trends

• Adoption of Immunotherapy: Growing use of immune system-based treatments.
• Biologic Therapies: Advances in therapies targeting biological pathways.
• Probiotic-Based Treatments: Integration of probiotics in allergy management.
• Delivery System Innovations: Technological improvements in treatment delivery.
• Personalized Medicine: Tailored approaches for individual patients.
• Regulatory Support: Increased approvals and support from regulatory bodies.

Driving Growth Through Research and Development Investment
Significance of R&D Investment

• Innovation and Advancement: Essential for developing new peanut allergy therapies.
• Desensitization Techniques: Creating methods to reduce allergic reactions.
• Quality of Life: Aiming to improve living standards for those with peanut allergies.

Example of R&D Investment

• Victorian Government’s Initiative: A $12 million investment in Aravax to advance the PVX108 immunotherapy.
• Impact: Secured Phase 2 trial approvals from the FDA and TGA, highlighting global health potential.

Major Players in the Market
Leading Companies

• Pharmaceutical Giants: Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi SA, Novartis AG, Takeda Pharmaceutical Company Limited.
• Other Key Players: Viatris Inc., Regeneron Pharmaceuticals Inc., Hikma Pharmaceuticals plc, ALK-Abelló A/S, Amneal Pharmaceuticals Inc.
• Specialized Firms: Stallergenes Greer plc, kaleo Inc., Aquestive Therapeutics Inc., Vedanta Biosciences Inc., Aimmune Therapeutics Inc.

Advancements in Peanut Allergy Treatment
Focus on Anti-IgE Monoclonal Antibodies

• Targeted Therapies: Development of biologic therapies like anti-IgE monoclonal antibodies.
• Example: Novartis’s Xolair (omalizumab), approved by the FDA in February 2024, shows significant improvement in food allergy tolerance.

Expansion Through Strategic Acquisitions
Stallergenes Greer’s Acquisition

• Acquisition of Palforzia: In September 2023, Stallergenes Greer acquired Palforzia from Nestlé S.A.
• Portfolio Enhancement: This acquisition expands Stallergenes Greer’s allergy treatment offerings.

Market Segmentation
Drug Class

• Antihistamines
• Immunotherapies
• Epinephrine
• Other Drug Classes

Route of Administration

• Injectable
• Oral
• Other Routes

Distribution Channel

• Retail Pharmacy
• Hospital Pharmacy
• Other Channels

Regional Insights

• North America: Largest market region in 2023.
• Asia-Pacific: Expected to be the fastest-growing region during the forecast period.

Conclusion
The peanut allergy treatment market is poised for significant growth, driven by advancements in research, increasing prevalence of allergies, and innovations in treatment approaches. Investment in R&D and strategic acquisitions by major companies will continue to propel the market forward, offering improved solutions and better quality of life for those affected by peanut allergies.

Request A Sample Of The Global Peanut Allergy Treatment Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15888&type=smp